在慢性阻塞性肺病的稳定和恶化阶段对原血栓生物标志物的评估:一项病例对照研究
Kamlesh K Gupta1, Shantanu Singh1, Virendra Atam1
1Internal Medicine, King George's Medical University, Lucknow, IND.
Cureus
|September 8, 2025
概括
慢性阻塞性肺病 (AECOPD) 的急性恶化显示出像纤维素素,D-二次体和·威尔布兰德因子 (vWF) 这样的前血栓生物标志物升高. 这些标记有助于检测和分层AECOPD风险.
科学领域:
- 肺部医学 肺部医学
- 心血管医学 心血管医学
- 生物标志物研究 生物标志物研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种具有心血管影响的系统性疾病.
- 慢性肺炎的急性恶化 (AECOPD) 增加了心血管风险,可能是通过前血栓状态.
研究的目的:
- 为了评估和比较稳定的COPD与AECOPD患者中的前血栓生物标志物水平.
- 评估生物标志物的诊断和预后意义,包括纤维素素,CRP,D-二次体,vWF,同类半素,LDH和PLR.
主要方法:
- 一项病例对照研究,涉及30名稳定的COPD和30名AECOPD患者 (年龄在30-80岁).
- 使用ELISA对血清纤维素素,D-二次体,vWF和CRP的分析.
- 统计分析包括t测试,Chi平方和ROC曲线分析.
主要成果:
- 与稳定的COPD相比,在AECOPD组中观察到血清纤维素,D-二次体和vWF水平明显升高.
- 纤维素 (AUC=0.89),D-二次体 (AUC=0.82),和vWF (AUC=0.74) 显示出对AECOPD.的强大的歧视力.
- 其他生物标志物 (homocysteine,LDH,PLR) 也在恶化期间升高,与疾病严重程度相关.
结论:
- AECOPD与显著的原血栓状况有关.
- 纤维素素,vWF和D-二次体显示出早期检测和AECOPD风险分层的潜力.
- 将这些生物标志物纳入COPD监测可以改善临床决策和指导治疗.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
329
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
329